Flow cytometry, cell viability assays, tumor-bearing mouse models, and HCC clinical specimens were used to validate the role of the AKT-WTAP-GLS axis in ferroptosis resistance and tumor progression. The gene discussed is AKT1; the disease is neoplasm.